Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2
Mease, Philip J, Lertratanakul, Apinya, Anderson, Jaclyn K, Papp, Kim, Van den Bosch, Filip, Tsuji, Shigeyoshi, Dokoupilova, Eva, Keiserman, Mauro, Wang, Xin, Zhong, Sheng, McCaskill, Reva M, Zueger, Patrick, Pangan, Aileen L, Tillett, William
Published in Annals of the rheumatic diseases (01.03.2021)
Published in Annals of the rheumatic diseases (01.03.2021)
Get full text
Journal Article
Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 Study
Mease, Philip J., Lertratanakul, Apinya, Papp, Kim A., van den Bosch, Filip E., Tsuji, Shigeyoshi, Dokoupilova, Eva, Keiserman, Mauro W., Bu, Xianwei, Chen, Liang, McCaskill, Reva M., Zueger, Patrick, McDearmon-Blondell, Erin L., Pangan, Aileen L., Tillett, William
Published in Rheumatology and therapy. (01.06.2021)
Published in Rheumatology and therapy. (01.06.2021)
Get full text
Journal Article
Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials
Burmester, Gerd R., Winthrop, Kevin, Blanco, Ricardo, Nash, Peter, Goupille, Philippe, Azevedo, Valderilio F., Salvarani, Carlo, Rubbert-Roth, Andrea, Lesser, Elizabeth, Lippe, Ralph, Lertratanakul, Apinya, Mccaskill, Reva M., Liu, John, Ruderman, Eric M.
Published in Rheumatology and therapy. (01.04.2022)
Published in Rheumatology and therapy. (01.04.2022)
Get full text
Journal Article
Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritis
Nash, Peter, Richette, Pascal, Gossec, Laure, Marchesoni, Antonio, Ritchlin, Christopher, Kato, Koji, McDearmon-Blondell, Erin L, Lesser, Elizabeth, McCaskill, Reva, Feng, Dai, Anderson, Jaclyn K, Ruderman, Eric M
Published in Rheumatology (03.08.2022)
Published in Rheumatology (03.08.2022)
Get full text
Journal Article
P185 Long-term efficacy and safety of upadacitinib in patients with psoriatic arthritis refractory to biologic therapies: 2-year results from the phase 3 SELECT-PsA 2 study
Mease, Philip J, Setty, Arathi, Papp, Kim, Van den Bosch, Filip, Tsuji, Shigeyoshi, Keiserman, Mauro, Bu, Xianwei, Chen, Liang, Mccaskill, Reva, Mcdearmon-Blondell, Erin, Wung, Peter, Tillett, William
Published in Rheumatology (Oxford, England) (24.04.2023)
Published in Rheumatology (Oxford, England) (24.04.2023)
Get full text
Journal Article
Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics: 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 study
Mease, Philip, Setty, Arathi, Papp, Kim, Van den Bosch, Filip, Tsuji, Shigeyoshi, Keiserman, Mauro, Carter, Kyle, Li, Yihan, McCaskill, Reva, McDearmon-Blondell, Erin, Wung, Peter, Tillett, William
Published in Clinical and experimental rheumatology (01.11.2023)
Published in Clinical and experimental rheumatology (01.11.2023)
Get more information
Journal Article